Oct 2 (Reuters) - Antisense Therapeutics Ltd (ANP) :
- Advised by FDA that full clinical hold for phase IIb clinical study of ATL1102 for multiple sclerosis has been lifted
- Co's application to conduct clinical trial of ATL1102 has been approved by Human Research Ethics Committee
- Forums
- ASX - By Stock
- PER
- News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study
News: ANP Antisense Therapeutics says FDA lifts hold for multiple sclerosis drug study
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 514630 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 124708 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 514630 | 0.100 |
1 | 13154 | 0.099 |
1 | 13000 | 0.098 |
3 | 140927 | 0.097 |
1 | 10004 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 124708 | 3 |
0.110 | 258351 | 2 |
0.115 | 618332 | 6 |
0.120 | 381142 | 9 |
0.125 | 110429 | 2 |
Last trade - 09.20am 02/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
Day chart unavailable
The Watchlist
BM8
BATTERY AGE MINERALS LTD
Nigel Broomham, CEO
Nigel Broomham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online